386 related articles for article (PubMed ID: 32931721)
1. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.
Yaseen MM; Abuharfeil NM; Darmani H; Daoud A
Open Biol; 2020 Sep; 10(9):200111. PubMed ID: 32931721
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis.
Müller I; Janson L; Sauter M; Pappritz K; Linthout SV; Tschöpe C; Klingel K
Viruses; 2021 May; 13(5):. PubMed ID: 34065891
[TBL] [Abstract][Full Text] [Related]
3. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1/PD-1 Axis.
Ruan WS; Feng MX; Xu J; Xu YG; Song CY; Lin LY; Li L; Lu YQ
Front Immunol; 2020; 11():1299. PubMed ID: 32719675
[No Abstract] [Full Text] [Related]
4. Programmed Death-Ligand 1 Expression Potentiates the Immune Modulatory Function Of Myeloid-Derived Suppressor Cells in Systemic Lupus Erythematosus.
Park MJ; Baek JA; Choi JW; Jang SG; Kim DS; Park SH; Cho ML; Kwok SK
Front Immunol; 2021; 12():606024. PubMed ID: 33986739
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells in Sepsis.
Schrijver IT; Théroude C; Roger T
Front Immunol; 2019; 10():327. PubMed ID: 30873175
[TBL] [Abstract][Full Text] [Related]
6. Mutualistic Effects of the Myeloid-Derived Suppressor Cells and Cancer Stem Cells in the Tumor Microenvironment.
Tanriover G; Aytac G
Crit Rev Oncog; 2019; 24(1):61-67. PubMed ID: 31679221
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections.
Tamadaho RSE; Hoerauf A; Layland LE
Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
Li X; Li Y; Yu Q; Qian P; Huang H; Lin Y
J Leukoc Biol; 2021 Aug; 110(2):257-270. PubMed ID: 34075637
[TBL] [Abstract][Full Text] [Related]
9. Persistent lentivirus infection induces early myeloid suppressor cells expansion to subvert protective memory CD8 T cell response
Liu L; Lin Q; Peng J; Fang J; Tan Z; Tang H; Kwan K; Nishiura K; Liang J; Kwok H; Du Z; Sun J; Liu K; Yuen KY; Wang H; Chen Z
EBioMedicine; 2020 Oct; 60():103008. PubMed ID: 32979832
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells: Important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significance.
Asgarzade A; Ziyabakhsh A; Asghariazar V; Safarzadeh E
Hum Immunol; 2021 Oct; 82(10):782-790. PubMed ID: 34272089
[TBL] [Abstract][Full Text] [Related]
11. Expansion and activation of monocytic-myeloid-derived suppressor cell via STAT3/arginase-I signaling in patients with ankylosing spondylitis.
Liu YF; Zhuang KH; Chen B; Li PW; Zhou X; Jiang H; Zhong LM; Liu FB
Arthritis Res Ther; 2018 Aug; 20(1):168. PubMed ID: 30075733
[TBL] [Abstract][Full Text] [Related]
12. Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy.
Wennerberg E; Lundqvist A; Mao Y; Mougiakakos D
Front Immunol; 2021; 12():718844. PubMed ID: 34276709
[No Abstract] [Full Text] [Related]
13. Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.
Stiff A; Trikha P; Mundy-Bosse B; McMichael E; Mace TA; Benner B; Kendra K; Campbell A; Gautam S; Abood D; Landi I; Hsu V; Duggan M; Wesolowski R; Old M; Howard JH; Yu L; Stasik N; Olencki T; Muthusamy N; Tridandapani S; Byrd JC; Caligiuri M; Carson WE
Clin Cancer Res; 2018 Apr; 24(8):1891-1904. PubMed ID: 29363526
[No Abstract] [Full Text] [Related]
14. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-Derived Suppressor Cells.
Gabrilovich DI
Cancer Immunol Res; 2017 Jan; 5(1):3-8. PubMed ID: 28052991
[TBL] [Abstract][Full Text] [Related]
16. MDSCs in infectious diseases: regulation, roles, and readjustment.
Dorhoi A; Glaría E; Garcia-Tellez T; Nieuwenhuizen NE; Zelinskyy G; Favier B; Singh A; Ehrchen J; Gujer C; Münz C; Saraiva M; Sohrabi Y; Sousa AE; Delputte P; Müller-Trutwin M; Valledor AF
Cancer Immunol Immunother; 2019 Apr; 68(4):673-685. PubMed ID: 30569204
[TBL] [Abstract][Full Text] [Related]
17. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
18. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses.
Kontaki E; Boumpas DT; Tzardi M; Mouzas IA; Papadakis KA; Verginis P
Autoimmunity; 2017 May; 50(3):170-181. PubMed ID: 28276713
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection.
Yaseen MM; Abuharfeil NM; Darmani H
Open Biol; 2021 Nov; 11(11):210216. PubMed ID: 34753323
[TBL] [Abstract][Full Text] [Related]
20. Activities of stromal and immune cells in HPV-related cancers.
Barros MR; de Melo CML; Barros MLCMGR; de Cássia Pereira de Lima R; de Freitas AC; Venuti A
J Exp Clin Cancer Res; 2018 Jul; 37(1):137. PubMed ID: 29976244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]